IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.

Kurte M, Luz-Crawford P, Vega-Letter AM, Contreras RA, Tejedor G, Elizondo-Vega R, Martinez-Viola L, Fernández-O'Ryan C, Figueroa FE, Jorgensen C, Djouad F, Carrión F

Open source

DOI: 10.3389/fimmu.2018.00802
Published: 2018
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2018.00802,
  title = {IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.},
  author = {Kurte M and Luz-Crawford P and Vega-Letter AM and Contreras RA and Tejedor G and Elizondo-Vega R and Martinez-Viola L and Fernández-O'Ryan C and Figueroa FE and Jorgensen C and Djouad F and Carrión F},
  year = {2018},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2018.00802},
  url = {https://doi.org/10.3389/fimmu.2018.00802}
}

RIS

TY  - JOUR
TI  - IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.
AU  - Kurte M
AU  - Luz-Crawford P
AU  - Vega-Letter AM
AU  - Contreras RA
AU  - Tejedor G
AU  - Elizondo-Vega R
AU  - Martinez-Viola L
AU  - Fernández-O'Ryan C
AU  - Figueroa FE
AU  - Jorgensen C
AU  - Djouad F
AU  - Carrión F
PY  - 2018
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2018.00802
UR  - https://doi.org/10.3389/fimmu.2018.00802
ER  -

APA

M, K., P, L., AM, V., RA, C., G, T., R, E., L, M., C, F., FE, F., C, J., F, D., & F, C. (2018). IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2018.00802

Source records

pubmed · retrieved 2026-09-27T09:49:55.158Z
europe-pmc · retrieved 2026-09-27T09:49:55.160Z
doaj · retrieved 2026-09-27T09:49:55.179Z
hal · retrieved 2026-09-27T09:49:55.233Z